Condition | Indicated | Relationship Strength | Studies | Trials |
Genetic Predisposition [description not available] | 0 | 2.31 | 1 | 0 |
2019 Novel Coronavirus Disease [description not available] | 0 | 2.31 | 1 | 0 |
Cancer of Prostate [description not available] | 0 | 2.15 | 1 | 0 |
Prostatic Neoplasms Tumors or cancer of the PROSTATE. | 0 | 2.15 | 1 | 0 |
Blood Poisoning [description not available] | 0 | 2.17 | 1 | 0 |
Di Guglielmo Disease [description not available] | 0 | 2.17 | 1 | 0 |
Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. | 0 | 2.46 | 2 | 0 |
Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. | 0 | 2.17 | 1 | 0 |
Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. | 0 | 2.17 | 1 | 0 |
Erythroblastosis Fetalis [description not available] | 0 | 2.04 | 1 | 0 |
Icterus Gravis Neonatorum [description not available] | 0 | 2.04 | 1 | 0 |
Jaundice, Neonatal Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES. | 0 | 2.04 | 1 | 0 |
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. | 0 | 2.04 | 1 | 0 |
Anemia, Hemolytic, Acquired [description not available] | 0 | 2.08 | 1 | 0 |
Extravascular Hemolysis [description not available] | 0 | 2.44 | 2 | 0 |
Autoimmune Thrombocytopenia [description not available] | 0 | 2.08 | 1 | 0 |
Anemia, Hemolytic A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). | 0 | 2.08 | 1 | 0 |
Hemoglobinuria The presence of free HEMOGLOBIN in the URINE, indicating hemolysis of ERYTHROCYTES within the vascular system. After saturating the hemoglobin-binding proteins (HAPTOGLOBINS), free hemoglobin begins to appear in the urine. | 0 | 2.08 | 1 | 0 |
Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. | 0 | 2.44 | 2 | 0 |
Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms. | 0 | 2.08 | 1 | 0 |
Pyrexia [description not available] | 0 | 2.01 | 1 | 0 |
Icterus [description not available] | 0 | 2.01 | 1 | 0 |
Diffuse Mixed Small and Large Cell Lymphoma [description not available] | 0 | 2.01 | 1 | 0 |
Ache [description not available] | 0 | 2.01 | 1 | 0 |
Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. | 0 | 2.01 | 1 | 0 |
Jaundice A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. | 0 | 2.01 | 1 | 0 |
Lymphoma, Non-Hodgkin Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. | 0 | 2.01 | 1 | 0 |
Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. | 0 | 2.01 | 1 | 0 |
Acute Hemolytic Transfusion Reaction [description not available] | 0 | 2.93 | 1 | 0 |
Transfusion Reaction Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility. | 0 | 2.93 | 1 | 0 |
Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. | 0 | 2.92 | 1 | 0 |
Graft-Versus-Host Disease [description not available] | 0 | 2.92 | 1 | 0 |
Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. | 0 | 2.92 | 1 | 0 |